Biotech

All Articles

2 cancer cells biotechs combine, creating international footprint

.OncoC4 is actually taking AcroImmune-- and its own internal professional manufacturing functionalit...

Amgen files 1st period 3 gain for $400M eczema drug

.Amgen has actually shared (PDF) the very first period 3 records on its own $400 million dermatitis ...

Biogen, UCB record period 3 lupus gain after falling short earlier trial

.Biogen and also UCB's rely on developing in to period 3 astride a broken research aims to have paid...

Aptadir wishes new RNA preventions can turn around complicated cancers cells

.Italian biotech Aptadir Therapeutics has actually released along with the commitment that its pipe ...

Wave surfs DMD success to regulators' doors, delivering stockpile

.Wave Lifestyle Sciences has met its own target in a Duchenne muscular dystrophy (DMD) research stud...

Sanofi tweezes new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma crease, occ...

Achilles trickles cell therapy plan, prepares for discharges after missing 'commercial viability' targets

.Achilles Therapeutics has actually destroyed its method. The English biotech is knocking off on its...

Aligos declares phase 2 MASH gain, reducing liver excess fat approximately 46%

.Aligos Therapeutics is actually trumpeting a midstage gain in metabolic-dysfunction linked steatohe...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has actually acquired a significant boos...

Capricor markets Europe civil rights to late-stage DMD treatment for $35M

.Having actually gathered up the united state rights to Capricor Therapeutics' late-stage Duchenne m...